Roxall Medizin GmbH or Dr Beckmann Pharma GmbH

Roxall Medizin is a specialized German pharmaceutical company focused on the research, development, and production of products for the diagnosis and treatment of allergic diseases. The company offers a comprehensive portfolio of allergen extracts for skin prick testing and allergen-specific immunotherapy (ASIT), including subcutaneous (SCIT) and sublingual (SLIT) options. Roxall is particularly recognized for its innovation in cluster immunotherapy, which allows for a significantly faster build-up phase for patients compared to traditional protocols. Following the integration of Dr. Beckmann Pharma and the Spanish company Aristegui, Roxall has established a strong international presence across Europe. The company maintains high-quality manufacturing standards to produce standardized allergen preparations for clinical use by allergists and specialized clinics.